We're proud to announce that the U.S. FDA has granted Emergency Use Authorization for our OraQuick™ Ebola 2.0 Rapid Antigen Test.
Developed in partnership with BARDA.
Read press release→ bit.ly/4pyHaAx
Developed in partnership with BARDA.
Read press release→ bit.ly/4pyHaAx